Recent research has demonstrated that CoQ10 attenuates NLRP 3 inflammasome activation and IL-1β serum levels in multiple acyl-CoA dehydrogenase deficiency (MADD) and fibromyalgia (FM) patients [24, 25]. The gene discussed is IL1B; the disease is fibromyalgia.